Catena Biosciences — Biotech, Biotechnology. Catena Biosciences operates in Biotech, Biotechnology; this dossier captures the Series A we participated in.
via StoryHouse Fund II.
On Fri, May 22, 2026 at 11:28 Miles Bird [miles.t.bird@gmail.com](mailto:miles.t.bird@gmail.com) wrote: > RAW NOTES: > > Good update from Marco during dinner. > > According to Marco, while the deal is not yet closed, he feels more > confident because one of his advisors, Ron, is giving him an inside > perspective on the process, as he is in all…
Source: Meeting Notes rec90AOFblGybtyg0
RAW NOTES: 1. Jennifer Doudna / Event with StoryHouse + Baker Labs • Marco said Jennifer Doudna’s engagement with the company has been lower recently, largely because their current work isn’t directly focused on the CRISPR side of the field. • He’s had mixed success getting her involved in external events. • However, she’s increasingly inte…
Source: Meeting Notes recsW4izpTmObHptZ